OPUS GENETICS INC. -
1,1000
25-ноября-24 15:45:01
15 мин. задержка
Акции
+0,0900
+8,91%
Сегодняшний диапазон
1,0200 - 1,1200
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Opus Genetics Announces Financial Results for Third Quarter 2024 and Provides Corporate Update
12 ноя 2024 07:00:02 Источник Nasdaq GlobeNewswire
-
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12 ноя 2024 06:59:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Acquisition of Opus Genetics
22 окт 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
30 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
05 сен 2024 19:43:59 Источник Nasdaq GlobeNewswire
-
05 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update
13 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Two Investor Conferences in August
08 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July
10 июл 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
06 июн 2024 06:57:22 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
10 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
06 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at the Aegis Virtual Conference
03 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
22 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
01 апр 2024 06:14:52 Источник Nasdaq GlobeNewswire
-
08 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present in the BIO CEO & Investor Conference
23 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 фев 2024 15:10:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
14 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >